NCT00794599

Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03182)

Preference Evaluation of Clarinex Tablets vs. Zyrtec Tablets in Subjects With Symptomatic Allergic Rhinitis

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 118 (actual)
• Sponsor: Organon and Co · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This was a crossover study designed to see if patients with allergy symptoms preferred Clarinex® or Zyrtec®. Patients were randomized to take 7 days of Clarinex or Zyrtec treatment, followed by a 5 to 28-day washout period (days when no drug is given), followed by 7 days of the opposite treatment. At the end of each 7-day treatment, patients were asked questions to determine which drug, Clarinex or Zyrtec, the patient prefers more.

Conditions

• Seasonal Allergic Rhinitis
• Perennial Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	Desloratadine 5 mg (Clarinex)	Clarinex 5 mg daily x 7 days
DRUG	Cetirizine (Zyrtec)	Zyrtec 10 mg daily x 7 days

Timeline

• Start date: 2002-12-01
• Primary completion: 2003-08-01
• Completion: 2003-08-01
• First posted: 2008-11-20
• Last updated: 2022-02-17